1-3 of 3
Anastazia Keegan
Close
Sort by
Journal Articles

Economic evaluation: immunoglobulin vs prophylactic antibiotics in hypogammaglobulinemia and hematological malignancies

Clinical Trials & Observations
Sara Carrillo de Albornoz, Alisa M. Higgins, Dennis Petrie, Adam Irving, Laura Fanning, Robert Weinkove, Philip Crispin, Claire Dendle, Michael Gilbertson, Anna Johnston, Anastazia Keegan, Dominic Pepperell, Humphrey Pullon, John Reynolds, Tina van Tonder, Judith Trotman, Neil Waters, Cameron Wellard, Helen Weston, C. Orla Morrissey, Erica M. Wood, Zoe K. McQuilten
Journal: Blood Advances
Blood Adv (2024) 8 (9): 2259–2267.
https://doi.org/10.1182/bloodadvances.2023012047
Published: 2024
Includes: Supplemental data
Journal Articles

Immunoglobulin replacement vs prophylactic antibiotics for hypogammaglobulinemia secondary to hematological malignancy

Clinical Trials & Observations
Zoe K. McQuilten, Robert Weinkove, Le Thi Phuong Thao, Philip Crispin, Amber Degelia, Claire Dendle, Michael Gilbertson, Anna Johnston, Anastazia Keegan, Dominic Pepperell, Humphrey Pullon, John Reynolds, Tina van Tonder, Judith Trotman, Neil Waters, Cameron Wellard, Helen Weston, C. Orla Morrissey, Erica M. Wood
Journal: Blood Advances
Blood Adv (2024) 8 (7): 1787–1795.
https://doi.org/10.1182/bloodadvances.2023011231
Published: 2024
Includes: Supplemental data
Journal Articles

Interventions to reduce infections in patients with hematological malignancies: a systematic review and meta-analysis

Khai Li Chai, Jonathan Wong, Robert Weinkove, Anastazia Keegan, Philip Crispin, Simon Stanworth, C. Orla Morrissey, Erica M. Wood, Zoe K. McQuilten
Journal: Blood Advances
Blood Adv (2023) 7 (1): 20–31.
https://doi.org/10.1182/bloodadvances.2022008073
Published: 2023
Includes: Supplemental data